Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease
2018-01-01 Fiorino, G; Ruiz-Arguello, Mb; Maguregui, A; Nagore, D; Correale, C; Radice, S; Gilardi, D; Allocca, M; Furfaro, F; Martinez, A; Danese, S
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
2012-01-01 Prantera, C; Lochs, H; Grimaldi, M; Danese, S; Scribano, Ml; Gionchetti, P
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease
2001-01-01 Papa, A; De Stefano, V; Danese, S; Chiusolo, P; Persichilli, S; Casorelli, I; Zappacosta, B; Giardina, B; Gasbarrini, A; Leone, G; Gasbarrini, G
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience
2011-01-01 Fiorino, G.; Szabò, H.; Walter, F.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S.
Adalimumab for ulcerative colitis: A little is better than none?
2012-01-01 Danese, S
Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation
2013-01-01 Indriolo, A; Fagiuoli, S; Pasulo, L; Fiorino, G; Danese, S; Ravelli, P
Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review
2019-01-01 Pariente, B; Hu, Sr; Bettenworth, D; Speca, S; Desreumaux, P; Meuwis, Ma; Danese, S; Rieder, F; Louis, E
Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence
2019-01-01 Olivera, P; Danese, S; Pouillon, L; Bonovas, S; Peyrin-Biroulet, L
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease
2020-01-01 Ungaro, Ryan C; Yzet, Clara; Bossuyt, Peter; Baert, Filip J; Vanasek, Thomas; D'Haens, Geert R; Joustra, Vincent Wilhelmus; Panaccione, Remo; Novacek, Gottfried; Reinisch, Walter; Armuzzi, Alessandro; Golovchenko, Oleksandr; Prymak, Olga; Goldis, Adrian; Travis, Simon P; Hébuterne, Xavier; Ferrante, Marc; Rogler, Gerhard; Fumery, Mathurin; Danese, Silvio; Rydzewska, Grazyna; Pariente, Benjamin; Hertervig, Erik; Stanciu, Carol; Serrero, Melanie; Diculescu, Mircea; Peyrin-Biroulet, Laurent; Laharie, David; Wright, John P; Gomollón, Fernando; Gubonina, Irina; Schreiber, Stefan; Motoya, Satoshi; Hellström, Per M; Halfvarson, Jonas; Butler, James W; Petersson, Joel; Petralia, Francesca; Colombel, Jean-Frederic
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
2010-01-01 Tursi, A; Brandimarte, G; Papa, A; Giglio, A; Elisei, W; Giorgetti, Gm; Forti, G; Morini, S; Hassan, C; Pistoia, Ma; Modeo, Me; Rodino', S; D'Amico, T; Sebkova, L; Sacca', N; Di Giulio, E; Luzza, F; Imeneo, M; Larussa, T; Di Rosa, S; Annese, V; Danese, S; Gasbarrini, A
Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosa
2014-01-01 Fiorino, G; Danese, S.
Integrins and adhesion molecules as targets to treat inflammatory bowel disease
2015-01-01 Bravata, I; Allocca, M; Fiorino, G; Danese, S
Endoclipping for gastric perforation secondary to second session of EMRC in locally residual early gastric cancer : a case report
2009-01-01 De Caro, G.; Pagano, N.; Malesci, A.; Hervoso, C.; Danese, S.; Romeo, F.; Delconte, G.; Repici, A.
Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease
2020-01-01 Daude, Sébastien; Remen, Thomas; Chateau, Thomas; Danese, Silvio; Gastin, Isabelle; Baumann, Cédric; Gueant, Jean Louis; Peyrin-Biroulet, Laurent
Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
2019-01-01 D'Amico, F; Roda, G; Peyrin-Biroulet, L; Danese, S
The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13 (vol 9, pg 17, 2015)
2016-01-01 Reinisch, W; Louis, E; Danese, S
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents
2017-01-01 Reinisch, W; Jahnsen, J; Schreiber, S; Danese, S; Panes, J; Balsa, A; Park, W; Kim, J; Lee, Ju; Yoo, Dh
TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review
2021-01-01 Muller, Marie; D'Amico, Ferdinando; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes
2009-01-01 Repici, A; Pellicano, R; Strangio, G; Danese, S; Fagoonee, S; Malesci, A
Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan
2020-01-01 Allocca, Mariangela; Guidelli, Giacomo Maria; Borroni, Riccardo G; Selmi, Carlo; Narcisi, Alessandra; Danese, Silvio; Fiorino, Gionata
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease | 1-gen-2018 | Fiorino, G; Ruiz-Arguello, Mb; Maguregui, A; Nagore, D; Correale, C; Radice, S; Gilardi, D; Allocca, M; Furfaro, F; Martinez, A; Danese, S | |
| Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease | 1-gen-2012 | Prantera, C; Lochs, H; Grimaldi, M; Danese, S; Scribano, Ml; Gionchetti, P | |
| Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease | 1-gen-2001 | Papa, A; De Stefano, V; Danese, S; Chiusolo, P; Persichilli, S; Casorelli, I; Zappacosta, B; Giardina, B; Gasbarrini, A; Leone, G; Gasbarrini, G | |
| Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience | 1-gen-2011 | Fiorino, G.; Szabò, H.; Walter, F.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S. | |
| Adalimumab for ulcerative colitis: A little is better than none? | 1-gen-2012 | Danese, S | |
| Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation | 1-gen-2013 | Indriolo, A; Fagiuoli, S; Pasulo, L; Fiorino, G; Danese, S; Ravelli, P | |
| Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review | 1-gen-2019 | Pariente, B; Hu, Sr; Bettenworth, D; Speca, S; Desreumaux, P; Meuwis, Ma; Danese, S; Rieder, F; Louis, E | |
| Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence | 1-gen-2019 | Olivera, P; Danese, S; Pouillon, L; Bonovas, S; Peyrin-Biroulet, L | |
| Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease | 1-gen-2020 | Ungaro, Ryan C; Yzet, Clara; Bossuyt, Peter; Baert, Filip J; Vanasek, Thomas; D'Haens, Geert R; Joustra, Vincent Wilhelmus; Panaccione, Remo; Novacek, Gottfried; Reinisch, Walter; Armuzzi, Alessandro; Golovchenko, Oleksandr; Prymak, Olga; Goldis, Adrian; Travis, Simon P; Hébuterne, Xavier; Ferrante, Marc; Rogler, Gerhard; Fumery, Mathurin; Danese, Silvio; Rydzewska, Grazyna; Pariente, Benjamin; Hertervig, Erik; Stanciu, Carol; Serrero, Melanie; Diculescu, Mircea; Peyrin-Biroulet, Laurent; Laharie, David; Wright, John P; Gomollón, Fernando; Gubonina, Irina; Schreiber, Stefan; Motoya, Satoshi; Hellström, Per M; Halfvarson, Jonas; Butler, James W; Petersson, Joel; Petralia, Francesca; Colombel, Jean-Frederic | |
| Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study | 1-gen-2010 | Tursi, A; Brandimarte, G; Papa, A; Giglio, A; Elisei, W; Giorgetti, Gm; Forti, G; Morini, S; Hassan, C; Pistoia, Ma; Modeo, Me; Rodino', S; D'Amico, T; Sebkova, L; Sacca', N; Di Giulio, E; Luzza, F; Imeneo, M; Larussa, T; Di Rosa, S; Annese, V; Danese, S; Gasbarrini, A | |
| Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosa | 1-gen-2014 | Fiorino, G; Danese, S. | |
| Integrins and adhesion molecules as targets to treat inflammatory bowel disease | 1-gen-2015 | Bravata, I; Allocca, M; Fiorino, G; Danese, S | |
| Endoclipping for gastric perforation secondary to second session of EMRC in locally residual early gastric cancer : a case report | 1-gen-2009 | De Caro, G.; Pagano, N.; Malesci, A.; Hervoso, C.; Danese, S.; Romeo, F.; Delconte, G.; Repici, A. | |
| Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease | 1-gen-2020 | Daude, Sébastien; Remen, Thomas; Chateau, Thomas; Danese, Silvio; Gastin, Isabelle; Baumann, Cédric; Gueant, Jean Louis; Peyrin-Biroulet, Laurent | |
| Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference? | 1-gen-2019 | D'Amico, F; Roda, G; Peyrin-Biroulet, L; Danese, S | |
| The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13 (vol 9, pg 17, 2015) | 1-gen-2016 | Reinisch, W; Louis, E; Danese, S | |
| Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents | 1-gen-2017 | Reinisch, W; Jahnsen, J; Schreiber, S; Danese, S; Panes, J; Balsa, A; Park, W; Kim, J; Lee, Ju; Yoo, Dh | |
| TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review | 1-gen-2021 | Muller, Marie; D'Amico, Ferdinando; Bonovas, Stefanos; Danese, Silvio; Peyrin-Biroulet, Laurent | |
| Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes | 1-gen-2009 | Repici, A; Pellicano, R; Strangio, G; Danese, S; Fagoonee, S; Malesci, A | |
| Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan | 1-gen-2020 | Allocca, Mariangela; Guidelli, Giacomo Maria; Borroni, Riccardo G; Selmi, Carlo; Narcisi, Alessandra; Danese, Silvio; Fiorino, Gionata |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1